Back to search

Poland· PL-100445549

Ramipril + Bisoprolol fumarate Aristo

A ace inhibitors, other combinations product containing ramiprilum + bisoprololi fumaras, registered in Poland by Aristo Pharma Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC C09BX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRamipril + Bisoprolol fumarate AristoATCC09BXREGISTER NO.PL-100445549PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Ramiprilum + bisoprololi fumaras is registered in 4 of 19 countries.

Countries holding a registration under ATC C09BX (ace inhibitors, other combinations), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Ramiprilum + bisoprololi fumaras · ATC C09BX

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ramiprilum + Bisoprololi fumaras
Manufacturer
Aristo Pharma Sp. z o.o.
Country
Poland (PL)
ATC code
C09BX
ATC class
ACE inhibitors, other combinations
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991493547
  • gtin
    05909991493554
  • gtin
    05909991493561
  • gtin
    05909991493578

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ramiprilum + bisoprololi fumaras in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ramiprilum + bisoprololi fumaras products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Ralanbi, Rambofort
  • Bulgaria · Вивейс Плюс, Калиса
  • Cyprus · Proramace
  • Czechia · Ralbior
  • Germany · Ramibiso Apontis, Ramipril/Bisoprolol Egis
  • Estonia · Bisramex
  • Spain · Rabidux, Ramipril/Bisoprolol Egis
  • Greece · Proramace
  • Croatia · Byol Combi, Ramipril/Bisoprololfumarat Elc
  • Hungary · Diptensa, Ramipril/Bisoprolol
  • Italy · Rabisop, Ramilolo
  • Lithuania · Bisramex
  • Latvia · Bisramex
  • Portugal · Rabidux, Ramipril + Bisoprolol Egis
  • Slovakia · Ralbior

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca4ce5bc-b58d-4af7-9043-c843c44935df
GET /v1/drugs/ca4ce5bc-b58d-4af7-9043-c843c44935df?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "10 mg + 5 mg",
  "packaging": "05909991493547 ¦ Rp ¦ 146414\n10 kaps.\n05909991493554 ¦ Rp ¦ 146415\n30 kaps.\n05909991493561 ¦ Rp ¦ 146416\n60 kaps.\n05909991493578 ¦ Rp ¦ 146417\n100 kaps.",
  "substance": "Ramiprilum 10 mg + Bisoprololi fumaras 5 mg",
  "common_name": "Ramiprilum + Bisoprololi fumaras",
  "pl_product_id": "100445549",
  "pozwolenie_nr": "27268",
  "auth_procedure": "DCP",
  "authorisation_validity": "2024-07-09"
}

See everything about ramiprilum + bisoprololi fumaras.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.